Fortrea Holdings Inc. (FTRE)
Health Care ยท Services-Medical Laboratories
Fortrea Holdings Inc. (FTRE) is listed on Nasdaq, where its shares have traded since June 16, 2023. SentiSense covers Fortrea Holdings Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories. Anshul Thakral is its chief executive officer. The company reports 14,000 employees, and its corporate website is www.fortrea.com.
About Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Latest reported results
Fortrea Holdings Inc. reported revenue of $691.5 million for Q3 FY2026, down 1.4% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 323 institutions reported holding FTRE, with 99.7 million shares worth $1.7 billion in aggregate. The largest reported holders were BlackRock, Vanguard and Goldman Sachs. Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
More on FTRE
- FTRE sentiment: whether news and social coverage of Fortrea Holdings Inc. leans bullish or bearish, and the stories driving it.
- FTRE ownership: all 323 reporting institutions, plus insider and congressional trades.
- FTRE financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Fortrea Holdings Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Fortrea Holdings Inc. do?
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions.
What sector is FTRE in?
SentiSense classifies Fortrea Holdings Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories.
Where does FTRE stock trade?
Fortrea Holdings Inc. (FTRE) is listed on Nasdaq, where its shares have traded since June 16, 2023.
Who is the CEO of Fortrea Holdings Inc.?
Anshul Thakral is the chief executive officer of Fortrea Holdings Inc..